派林生物(000403.SZ)：人凝血酶药品注册临床试验获受理

Core Viewpoint - The company Palin Bio (000403.SZ) announced that its wholly-owned subsidiary, Guangdong Shuanglin Biopharmaceutical Co., Ltd., has received the clinical trial acceptance notice for human thrombin drug registration from the National Medical Products Administration [1] Group 1 - The indication for human thrombin is for external use only, aimed at controlling minor bleeding from capillaries and small veins when standard surgical techniques are ineffective or impractical [1] - The product can be used in conjunction with absorbable gelatin sponges [1]